IMMUNEOS Trademark

Trademark Overview


On Wednesday, December 24, 2025, a trademark application was filed for IMMUNEOS with the United States Patent and Trademark Office. The USPTO has given the IMMUNEOS trademark a serial number of 99564552. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, May 7, 2026. This trademark is owned by Immunevax. The IMMUNEOS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research consultancy; Providing scientific research information; Providing medical and scientific research information; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing information about medical and scientific research; Scientific research in the field of quantum computing; Providing scientific research information in the field of pharmaceuticals; Scientific research and development in the field of mRNA drugs; Providing medical research and scientific research information in the field of oncology via the Internet; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others...
immuneos

General Information


Serial Number99564552
Word MarkIMMUNEOS
Filing DateWednesday, December 24, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, May 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2026

Trademark Statements


Goods and ServicesScientific research consultancy; Providing scientific research information; Providing medical and scientific research information; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing information about medical and scientific research; Scientific research in the field of quantum computing; Providing scientific research information in the field of pharmaceuticals; Scientific research and development in the field of mRNA drugs; Providing medical research and scientific research information in the field of oncology via the Internet; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications
Pseudo MarkIMMUNE OS

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 24, 2025
Primary Code042
First Use Anywhere DateWednesday, November 12, 2025
First Use In Commerce DateWednesday, November 12, 2025

Trademark Owner History


Party NameImmunevax
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMarietta, GA 30066
US

Trademark Events


Event DateEvent Description
Wednesday, December 24, 2025NEW APPLICATION ENTERED
Wednesday, December 24, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, April 15, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 27, 2026ASSIGNED TO EXAMINER
Friday, May 1, 2026APPROVED FOR PUB - PRINCIPAL REGISTER